Cell therapies show promise in Parkinson’s disease, but there’s an ongoing debate over which therapy works best. Some believe in using an autologous therapy, while others believe an allogeneic approach, would be more cost-effective. As the discussion moves forward, we must carefully assess all the evidence and make the right decisions based on the best, currently available data.
The post An Autologous Stem Cell-Based Therapy for Parkinson’s Disease appeared first on GEN – Genetic Engineering and Biotechnology News.
Published on Wed, 25 Nov 2020 18:49:53 +0000 with keywords power automate replace text in array